Sort
89,613 grants matching “depression”
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$2,222,489Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2010 · GM
Mental Stress Ischemia: Prognosis and Genetic Influences
$2,222,147Arshed A Quyyumi · Emory University · P01 · FY2011 · HL
CORBE: CENTER FOR PSYCHIATRIC NEUROSCIENCE
$2,222,070Craig Allen Stockmeier · University Of Mississippi Med Ctr · P20 · FY2007 · RR
Mental Health Research Network III
$2,220,745Gregory E Simon · Kaiser Foundation Research Institute · U19 · FY2019 · MH
The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)
$2,220,447Martin P Paulus · Laureate Institute For Brain Research · P20 · FY2020 · GM
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,219,794Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
The Community Youth Development Study: A Test of Communities That Care
$2,218,376J David Hawkins · University Of Washington · R01 · FY2011 · DA
Reversing opioid-induced hypoxemia with novel thiol-based drugs without compromising analgesia in goats
$2,218,043Matthew Robert Hodges · Medical College Of Wisconsin · RF1 · FY2022 · DA
A Reinforcement Approach to Improve Diabetes Management
$2,215,737Nancy M Petry · University Of Connecticut Sch Of Med/Dnt · DP3 · FY2012 · DK
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$2,215,574David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
Integration of Geriatric Care into Dialysis Clinics
$2,214,990Rasheeda K Hall · Duke University · RF1 · FY2025 · AG
Biobehavioral Bases of CHD Risk and Management
$2,214,816Neil Schneiderman · University Of Miami Coral Gables · P01 · FY2008 · HL
Mental Stress Ischemia: Prognosis and Genetic Influences
$2,213,556Arshed A Quyyumi · Emory University · P01 · FY2013 · HL
Neurobiology of Substance Abuse & Addiction - Preclinical Studies
$2,213,543Nora D. Volkow · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA
Emory Conte Center for Neuroscience of Mental Disorders
$2,212,925Charles B Nemeroff · Emory University · P50 · FY2006 · MH
Integrative Neurobiology of Cardiovascular Regulation
$2,211,768University Of Iowa · P01 · FY2004 · HL
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,211,352Redford B Williams · Duke University · P01 · FY2012 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,209,929Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Emory Conte Center for Neuroscience of Mental Disorders
$2,209,799Emory University · P50 · FY2005 · MH
Chicago WIHS Consortium V (CWC)
$2,209,223Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2016 · AI
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$2,209,057David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
THE NEUROBIOLOGY OF SUICIDAL BEHAVIOR
$2,208,625New York State Psychiatric Institute · P50 · FY2003 · MH
COBRE for Stress, Trauma and Resilience (STAR)
$2,206,835Laura R Stroud · Miriam Hospital · P20 · FY2024 · GM
Clinic, Family & Community Collaboration to Treat Overweight and Obese Children
$2,205,736Thomas N Robinson · Stanford University · U01 · FY2013 · HL
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
$2,205,587Phillip O Coffin · Public Health Foundation Enterprises · U01 · FY2020 · DA